TrialNature communications2024

Neoadjuvant camrelizumab and apatinib combined with chemotherapy versus chemotherapy alone for locally advanced gastric cancer: a multicenter randomized phase 2 trial.

Jian-Xian Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.